“The Double-Dare of Cholesterol: Why Indian Patients Need Both LDL and ApoB to Outwit Heart & Kidney Risk ”. 2025. Diabzen 3 (2): 35-38. https://www.thediabzen.com/index.php/d/article/view/17.